Table 2

Cohort eligible for analysis, CPS-I and CPS-II

CPS-ICPS-II
No. of menaNo. of deaths, prostate canceraNo. of menaNo. of deaths, prostate cancera
Full cohort456,4902,277508,3515,414
Exclusions
 Prevalent prostate cancer508 (0.1)192 (8.4)3,314 (0.7)1,003 (18.5)
 Other prevalent cancersb19,117 (4.2)198 (8.7)21,928 (4.3)396 (7.3)
 Missing race3,616 (0.8)21 (0.9)2,309 (0.5)20 (0.4)
 Missing or extreme height, weight, or BMI26,243 (5.7)165 (7.2)15,963 (3.1)161 (3.0)
 Weight loss >10 pounds in past year25,368 (5.6)111 (4.9)30,207 (5.9)212 (3.9)
Total number of exclusions74,852 (16.4)687 (30.2)73,721 (14.5)1,792 (33.1)
Total number available for analysis381,6381,590434,6303,622
  • a Numbers in parentheses, percentages.

  • b Cancer reported at enrollment other than nonmelanoma skin cancer.